HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New laboratory evidence for the association between endothelial dysfunction and COVID-19 disease progression.

Abstract
There is growing evidence that angiotensin-converting enzyme 2 is highly expressed on endothelial cells, endothelial dysfunction plays a critical role in coronavirus disease 2019 (COVID-19) progression, but laboratory evidence is still lacking. This study established a multicenter retrospective cohort of 966 COVID-19 patients from three hospitals in Wuhan, China. We found that male (62.8% vs. 46.5%), old age [72 (17) vs. 60.5 (21)], and coexisting chronic diseases (88.5% vs. 60.0%) were associated with poor clinical prognosis in COVID-19. Furthermore, the deteriorated patients exhibited more severe multiorgan damage, coagulation dysfunction, and extensive inflammation. Additionally, a cross-sectional study including 41 non-COVID-19 controls and 39 COVID-19 patients assayed endothelial function parameters in plasma and showed that COVID-19 patients exhibited elevated vascular cell adhesion molecule-1 (VCAM-1) (median [IQR]: 0.32 [0.27] vs. 0.17 [0.11] μg/ml, p < 0.001), E-selectin (21.06 [12.60] vs. 11.01 [4.63] ng/ml, p < 0.001), tissue-type plasminogen activator (tPA) (0.22 [0.12] vs. 0.09 [0.04] ng/ml, p < 0.001), and decreased plasminogen activator inhibitor-1 (0.75 [1.31] vs 6.20 [5.34] ng/ml, p < 0.001), as compared to normal controls. Moreover, VCAM-1 was positively correlated with d-dimer (R = 0.544, p < 0.001); tPA was positively correlated with d-dimer (R = 0.800, p < 0.001) and blood urea nitrogen (R = 0.638, p < 0.001). Our findings further confirm the strong association between endothelial dysfunction and poor prognosis of COVID-19, which offers a rationale for targeting endothelial dysfunction as a therapeutic strategy for COVID-19.
AuthorsNan Liu, Hui Long, Jianhua Sun, Huan Li, Yunting He, Qiang Wang, Kai Pan, Yongliang Tong, Bingshun Wang, Qingming Wu, Likun Gong
JournalJournal of medical virology (J Med Virol) Vol. 94 Issue 7 Pg. 3112-3120 (07 2022) ISSN: 1096-9071 [Electronic] United States
PMID35246853 (Publication Type: Journal Article, Multicenter Study)
Copyright© 2022 Wiley Periodicals LLC.
Chemical References
  • Biomarkers
  • Vascular Cell Adhesion Molecule-1
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • COVID-19 (complications, diagnosis)
  • Cross-Sectional Studies
  • Disease Progression
  • Endothelial Cells
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Vascular Cell Adhesion Molecule-1
  • Vascular Diseases (virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: